Splice-Switching Oligonucleotides for Cancer Treatment
Novel and mutation specific approach for targeting the previously “undruggable” RAS oncogenes
Published: 25th June 2019

Patents
- Patent family: WO2015091525A1
- Patent granted in US: US10266828
IP Status
- Patent application submitted
- Patented
Seeking
- Development partner
- Commercial partner
- Seeking investment